SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-078441
Filing Date
2020-06-30
Accepted
2020-06-30 08:20:25
Documents
1
Period of Report
2020-06-29

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4544
  Complete submission text file 0001104659-20-078441.txt   5851
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 25 BROADWAY 9TH FLOOR NEW YORK NY 10004
Business Address
Coleman Mark (Reporting) CIK: 0001658379 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37635 | Film No.: 201000495